Bold
Investors
ASX
Latest News
ASX Announcements
Companies
Home
ASX Announcements
CHM Announcements
CHM CDH17 Phase 1 clinical trial update…
CHM
CHIMERIC THERAPEUTICS LIMITED
Market sensitive
CHM CDH17 Phase 1 clinical trial update - New DL 3 data
Date and time
16 July 2026 at 7:04 pm
Announcement type
Company Update
Show details
Hide details
Category
Other
Report codes
11001
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASX
Open original PDF
CHM announcement history
Recent CHM announcements
CHM ceases enrolment in Phase 1 trial and Company update
Trading Halt
Application for quotation of securities - CHM
Quarterly Activities/Appendix 4C Cash Flow Report
Chimeric receives $1.62M advance on FY26 R&D tax incentive
Investor Presentation